Pfizer tablets significantly reduce the risk of death from COVID-19, the company says

Antiviral drugs are coming. A day after the UK approved MSD / Ridgeback’s molnupiravir for the treatment of vulnerable people infected with COVID-19 was reported by Pfizer on Friday to have an 89 percent reduced risk of hospitalization or death with its antiviral candidate. An interim analysis showed that its antiviral treatment, called Paxlovid, compared … Read more

Penn National lost more than $ 2.5 billion in valuation after loss of earnings, allegations against Barstool’s Portnoy

Delnice Penn National Gaming Inc. PENN, -21.08% on Thursday then fell by more than 20%. large loss of profit in the third quarter and allegations of sexual abuse against the founder of Barstool Sports. According to Dow Jones Market Data, the fall wiped out more than $ 2.5 billion of Penn National’s market capitalization, the … Read more

Packers QB Aaron Rodgers tested positive for COVID, turned out not to be vaccinated

GREEN BAY, Wis. (AP) – Quarterback Packers Aaron Rodgers has tested positive for COVID-19 and will reportedly miss Sunday’s game in Kansas City. The NFL was the first to report a positive test that was not immediately confirmed by either the team or Rodgers ’agent. See also: DraftKings, Caesars and Penn National – here’s how … Read more

Survey: The US health care system and the state of democracy abroad are perceived negatively

U.S. health care systems, including their handling of the COVID-19 pandemic, and the state of democracy in the country, are viewed negatively abroad, according to the latest Pew research center. report issued on Monday. A survey conducted in 17 developed economies with 18,850 respondents shows that the U.S. health care system is below average or … Read more

Moderna will postpone the application for approval of Covid vaccine in children

Vials of vaccine Modern Covid. MUNIR UZ ZAMAN / AFP / Getty Images Text size Modern said on Sunday that the regulatory approval of Covid-19 for use in adolescents aged 12 to 17 could be delayed until January, after the Food and Drug Administration said it needed additional time to assess the data. The Cambridge-based … Read more

error: Content is protected !!